Clinical trial patient pipeline for biotech
Reach pre-triaged, consenting patients in the US and Brazil. Segmented by therapeutic area, eligibility profile, and geography — all anonymized, all compliance-first.
How it works
BioTrials is the commercial surface on top of a real patient pipeline — not a purchased list.
Curated patient pipeline
We run free patient-facing platforms (TrialReferrals, ABuscaDaCura, Alma studies.) that pre-triage patients with our AI guide Alma, gather consent, and build a rich eligibility profile for each.
Anonymized + segmented
Patient records are anonymized and structured for querying. You see segment counts, eligibility distributions, geography — never PII.
Outreach through us
When your trial matches a segment, we re-contact those patients with an opt-in. Consenting patients are introduced to your research site. You never handle the patient data directly.
Two ways to engage
Start with self-serve analytics for feasibility work. Graduate to managed lead facilitation when you're ready to recruit.
Analytics
Query the pipeline on your own. Get aggregate stats for feasibility, trial design, and protocol validation — patient counts by condition, region, treatment history, eligibility signals. Low-commitment, low-cost.
Managed lead facilitation
We find the patients, handle re-consent, and deliver warm introductions to your sites. BioAlma stays intermediary end-to-end. Per-lead pricing or retainer.
Why BioTrials
- Built on top of real patient platforms — not purchased lists.
- Editorial-independent — we're not paid by pharma for content.
- HIPAA (US) and LGPD (Brazil) aligned by design.
- Part of the BioAlma family of biotech intelligence products.
Join the waitlist
We're onboarding the first cohort of biotech partners. Tell us a little about you and we'll be in touch.